HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 15 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 33,598,000 | $58,232,000 | 0.57% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,750,000 | $22,252,000 | 0.43% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,500,000 | $4,376,000 | 0.10% |
| Hudson Bay Capital Management LP | 4,000,000 | $6,931,000 | 0.09% |
| Calamos Advisors LLC | 10,000,000 | $17,436,000 | 0.06% |
| D. E. Shaw & Co., Inc. | 17,444,000 | $30,242,000 | 0.03% |
| BNP PARIBAS FINANCIAL MARKETS | 3,867,000 | $6,742,331,000 | 0.01% |
| JPMORGAN CHASE & CO | 2,816,000 | $4,910,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,843,000 | $3,168,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |